Maximin H5 (MH5)
is an amphibian antimicrobial peptide specifically
targeting Staphylococcus aureus. At pH 6, the peptide
showed an improved ability to penetrate (ΔΠ = 6.2 mN m–1) and lyse (lysis = 48%) Staphylococcus aureus membrane mimics, which incorporated physiological levels of lysylated
phosphatidylglycerol (Lys-PG, 60%), compared to that at pH 7 (ΔΠ
= 5.6 mN m–1 and lysis = 40% at pH 7) where levels
of Lys-PG are lower (40%). The peptide therefore appears to have optimal
function at pH levels known to be optimal for the organism’s
growth. MH5 killed S. aureus (minimum inhibitory
concentration of 90 μM) via membranolytic mechanisms that involved
the stabilization of α-helical structure (approximately 45–50%)
and showed similarities to the “Carpet” mechanism based
on its ability to increase the rigidity (C
s
–1 = 109.94 mN m–1) and thermodynamic
stability (ΔG
mix = −3.0)
of physiologically relevant S. aureus membrane mimics
at pH 6. On the basis of theoretical analysis, this mechanism might
involve the use of a tilted peptide structure, and efficacy was noted
to vary inversely with the Lys-PG content of S. aureus membrane mimics for each pH studied (R
2 ∼ 0.97), which led to the suggestion that under biologically
relevant conditions, low pH helps mediate Lys-PG-induced resistance
in S. aureus to MH5 antibacterial action. The peptide
showed a lack of hemolytic activity (<2% hemolysis) and merits
further investigation as a potential template for development as an
antistaphylococcal agent in medically and biotechnically relevant
areas.